2902199090 Other naphthenic hydrocarbons\Cyclic olefins and cyclic terpenes.Regulatory conditions:nothing.VAT:17.0%.Tax refund rate:9.0%.MFN tariff:2.0%.general tariff:30.0%
Product Name, component content
2902199090 other cyclanes, cyclenes and cyclotherpenes.Supervision conditions:None.VAT:17.0%.Tax rebate rate:9.0%.MFN tariff:2.0%.General tariff:30.0%
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Aaron | AR01H6WB-500g |
1,3-Cyclopentadiene, 1-methyl- |
96-39-9 | 95% | 500g |
$3007.00 | 2025-02-11 | |
| Aaron | AR01H6WB-100g |
1,3-Cyclopentadiene, 1-methyl- |
96-39-9 | 95% | 100g |
$1207.00 | 2025-02-11 |
Audited Supplier
1-Methylcyclopenta-1,3-diene (CAS: 96-39-9) is a cyclic diene compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural properties, serves as a valuable intermediate in the synthesis of complex organic molecules, including bioactive compounds and pharmaceuticals. Recent studies have explored its potential in drug discovery, material science, and catalysis, highlighting its importance in advancing scientific and industrial applications.
A recent study published in the Journal of Medicinal Chemistry investigated the role of 1-methylcyclopenta-1,3-diene as a precursor in the synthesis of novel anti-inflammatory agents. The researchers utilized a combination of computational modeling and experimental synthesis to design derivatives of the compound, which exhibited promising inhibitory effects on key inflammatory pathways. The study reported a significant reduction in pro-inflammatory cytokine production in vitro, suggesting potential therapeutic applications for conditions such as rheumatoid arthritis and inflammatory bowel disease.
In the field of material science, 1-methylcyclopenta-1,3-diene has been employed as a building block for the development of advanced polymers with tailored properties. A 2023 study in Advanced Materials demonstrated the compound's utility in creating high-performance elastomers with enhanced thermal stability and mechanical strength. These materials show potential for use in biomedical devices, such as drug delivery systems and tissue engineering scaffolds, owing to their biocompatibility and customizable characteristics.
Catalytic applications of 1-methylcyclopenta-1,3-diene have also been a focus of recent research. A team at the Massachusetts Institute of Technology (MIT) reported a breakthrough in asymmetric catalysis using the compound as a ligand in transition metal complexes. Their findings, published in Nature Catalysis, revealed unprecedented enantioselectivity in the synthesis of chiral pharmaceuticals, paving the way for more efficient and sustainable drug manufacturing processes.
Despite these advancements, challenges remain in the large-scale production and application of 1-methylcyclopenta-1,3-diene. Issues such as stability under physiological conditions and scalability of synthesis methods are areas of ongoing investigation. Future research directions may include the development of greener synthetic routes and the exploration of its potential in targeted drug delivery systems.
In conclusion, 1-methylcyclopenta-1,3-diene (CAS: 96-39-9) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its diverse applications, from drug discovery to material science, underscore its importance in advancing scientific knowledge and technological innovation. As research progresses, this compound is likely to play an increasingly prominent role in addressing critical challenges in healthcare and materials engineering.
